Trials / Completed
CompletedNCT02554981
Evaluation of Maintaining Visual Performance in Participants Who Engage in Electronic Visual Tasking While Using Restasis®
Evaluation of Maintaining Visual Performance Of Subjects Who Engage in Electronic Visual Tasking While Using Restasis (EMPOWER)
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 51 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
This study will evaluate the efficacy of Restasis® in participants with dry eye disease who engage in electronic visual tasking.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Cyclosporine 0.05% Ophthalmic Emulsion | Cyclosporine 0.05% Ophthalmic Emulsion (RESTASIS®) 1 drop instilled in each eye twice a day. |
Timeline
- Start date
- 2015-07-21
- Primary completion
- 2016-03-24
- Completion
- 2016-03-24
- First posted
- 2015-09-21
- Last updated
- 2017-06-01
- Results posted
- 2017-06-01
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02554981. Inclusion in this directory is not an endorsement.